二代测序(NGS)技术应用于临床肿瘤精准医学诊断的共识

参考文献:

[1] Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, Yntema H, Bakker E, Scheffer H, Bauer P. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016 Jan;24(1):2-5

[2] Luthra R, Chen H, Roy-Chowdhuri S, Singh RR. Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges. Cancers (Basel). 2015 Oct 14;7(4):2023-36

[3] Oliver GR, Hart SN, Klee EW. Bioinformatics for clinical next generation sequencing. Clin Chem. 2015 Jan;61(1):124-35.

[4] Vrijenhoek T, Kraaijeveld K, Elferink M, de Ligt J, Kranendonk E, Santen G, Nijman IJ, Butler D, Claes G, Costessi A, Dorlijn W, van Eyndhoven W, Halley DJ, van den Hout MC, van Hove S, Johansson LF, Jongbloed JD, Kamps R, Kockx CE, de Koning B, Kriek M, Deprez RL, Lunstroo H, Mannens M, Mook OR, Nelen M, Ploem C, Rijnen M, Saris JJ, Sinke R, Sistermans E, van Slegtenhorst M, Sleutels F, van der Stoep N, van Tienhoven M, Vermaat M, Vogel M, Waisfisz Q, Weiss JM, van den Wijngaard A, van Workum W, Ijntema H, van der Zwaag B, van IJcken WF, den Dunnen JT, Veltman JA, Hennekam R, Cuppen E. Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects. Eur J Hum Genet. 2015 Sep;23(9):1270

[5] Molecular Methods for Clinical Genetics and Oncology Testing; Approved Guideline—Third Edition MM01-A3

[6] Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods; Approved GuidelineMM13-A

[7] Quality Management for Molecular Genetic Testing; Approved Guideline MM20-A

[8] Comparison of immunohistochemistry with fluorescence in situ hybridization in determining the human epidermal growth factor receptor 2 status of breast cancer specimens: a multicenter study of 3 149 Chinese patients. Chin Med J 2014;127 (2): 246-253

[9] Frampton GM, Fichtenholtz A, Otto GA, Wang K, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013 Nov;31(11):1023-31.

[10] 詹启敏, 曾益新, 王珏, 姬云, 钱海利, 李晓燕, 孙石磊.《肿瘤个体化治疗检测技术指南(试行)》.

[11] 李艳,李金明. 《个体化医疗中的临床分子诊断》 人民卫生出版社 2013年8月

[12] NCCN临床实践指南:非小细胞肺癌(2016.V1)

[13] NCCN临床实践指南:结直肠癌(2016.V1)

[14] NCCN临床实践指南:乳腺癌(2016.V1)

[15] NCCN临床实践指南:肝癌(2016.V1)

[16] NCCN临床实践指南:胃癌(2016.V1)

[17] NCCN临床实践指南:白血病(2016.V1)

 

 

附件:

[1] NGS检测报告格式化模板

[2] 基因名称及基因突变的标准术语(NGS技术相关的标准术语、NGS数据生物信息学所涉及的标准术语。中英文对照)

[3] 临床肿瘤NGS诊断项目(test)的技术要求和质控

[4] CAGC 2015年度启动会议纪要

 

 

相关文章
留下回复